Repare Therapeutics' shrinking revenues and declining revenu...

Repare Therapeutics' shrinking revenues and declining revenue forecast could challenge its P/S maintenance, possibly hindering significant share price growth. Its low P/S is acceptable to shareholders considering future revenue stagnation.